Literature DB >> 11832103

[E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma].

B Zhang1, H Chen, X Yao, W Cong, M Wu.   

Abstract

OBJECTIVE: To study the significance of E-selectin and its ligand-sLeX in the metastasis of hepatocellular carcinoma (HCC).
METHODS: Flow cytometry and immunohistochemistry were used to detect the expression of E-selectin and its ligand-sLeX in HCC cell lines and in human HCC tissues.
RESULTS: The positive rate of E-selectin in vascular endothelial cells adjacent to cancer nest in tumors was 67.9% (19/28). In tumors accompanied with emboli or satellite foci, it was significantly higher than that without emboli or satellite foci (P < 0.05). The positive rate of E-selectin was not related to tumor size, tumor capsule, AFP, and the degree of differentiation. The positive expressions of sLeX in SMMU-7721, PLC/PRF/5 and HepGII cell lines were 7.03%, 63.35% and 97.29% respectively. The positive cells of sLeX were mainly distributed in the margin of tumors; the positive expression of sLeX in HCC cells in emboli or invasive tumor tissues was much higher than that in primary foci.
CONCLUSION: E-selectin and its ligand-sLeX are closely correlated with the metastasis of HCC.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11832103

Source DB:  PubMed          Journal:  Zhonghua Wai Ke Za Zhi        ISSN: 0529-5815


  1 in total

1.  Inhibition of adhesion and metastasis of HepG2 hepatocellular carcinoma cells in vitro by DNA aptamer against sialyl Lewis X.

Authors:  Xiao-Kang Wang; Yan Peng; Hao-Ran Tao; Fen-Fang Zhou; Chi Zhang; Fei Su; Shi-Pei Wang; Qing Liu; Li-Hua Xu; Xue-Kai Pan; Wei Xie; Mao-Hui Feng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2017-06-06
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.